Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

INDO US BIO-TECH LTD.

NSE : INDOUSBSE : 541304ISIN CODE : INE250Z01010Industry : AgricultureHouse : Private

BSE153.400 (0 %)

PREV CLOSE ( ) 153.40

OPEN PRICE ( ) 153.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 301

TODAY'S LOW / HIGH ( )153.00 153.40

52 WK LOW / HIGH ( )147.25 386

NSE152.22-3.68 (-2.36 %)

PREV CLOSE( ) 155.90

OPEN PRICE ( ) 155.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1792

TODAY'S LOW / HIGH( ) 150.20 158.90

52 WK LOW / HIGH ( )145 388.4

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 04-02 2004

Management Info

- Chairman Jagdish Ajudia - Managing Director

Registered Office

Address 309, Shanti Mall, Satadhar Char Rasta,Opp. Navrang Tower,Sola Road ,
Ahmedabad,
Gujarat-380061

Phone 079 2749 1807 / 9909043999

Email indous_jagdish@yahoo.co.in

Website www.indousagriseeds.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

11Sep Indo US Bio-Tech informs about certifi
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

21Jun Indo Us Bio-Tech informs about clarifi
Indo Us Bio-Tech has informed regarding error in standalone financial re..

24Apr Indo Us Bio-Tech informs about disclos
Indo Us Bio-Tech has informed that the Company does not fulfill any of t..

11Jan Indo Us Bio-Tech informs about complia
Indo Us Bio-Tech has enclosed a Certificate dated 08th Day of January, 2..

24Aug Indo US Bio Tech enters into RCO with
Indo US Bio-Tech has entered into a Rate Contract (RCO) with Chhattisgar..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	50.55	82.5099999999999
Gross Profit	50.18	88.0399999999999
Operating Profit	55.6	111.15
Net Sales	235.64	728.36

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bombay Burmah Trdg. (BSE) 1888.90 (6.91%)	M.Cap ( in Cr)13179.21
Kaveri Seed (BSE) 1287.55 (5.54%)	M.Cap ( in Cr)6623.04
Naturite Agro Prod. (BSE) 312.00 (4.75%)	M.Cap ( in Cr)165.24
Nath Bio-Genes (BSE) 159.20 (3.21%)	M.Cap ( in Cr)302.54
JK Agri Genetics (BSE) 344.00 (1.30%)	M.Cap ( in Cr)159.51

Shareholding Pattern

	PROMOTERS	70.17%
	NON-INSTITUTION	29.82%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

INDO US BIO-TECH LTD.